APPLICATIONS PUBLISHED 8 JANUARY 2003
Published: 1-Jul-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Lipid-based drug delivery systems for topical application
Liplasome Pharma 1272160*
Lipid-based drug delivery systems against parasitic infections
Liplasome Pharma 1272161*
Stabilised dry powder formulations
Dura Pharmaceuticals 1272162*
Pharmaceutical compsns
Novartis 1272163*
Method for stabilising particle size distribution of a powdery active principle dispersed in a liquid and uses thereof
CCL Pharma 1272164*
Acrylic enteric coating compsns
BPSI Holdings; Roehm 1272165*
Pharmaceutical compsns comprising fluvastatin
Novartis 1272166*
Hydrophilic/lipophilic polymeric matrix dosage formulation
Jagotec 1267167*
Small organic molecule regulators of cell proliferation
Curis 1272168*
Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
1411198 Ontario 1272169*
Ocular growth and nicotinic antagonists
Valley Forge Pharmaceuticals 1272170*
Synergistic compsns containing choline base and succinic acid for insulin resistance and diabetes
Verteletsky, Pavel Vasilievitch; Pomytkin, Igor Anatolievitch; Kolesova, Olga Evgenievna; Ukhanova, Tatiyana Jurievna 1272171*
Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
City of Hope 1272172*
Method of inhibiting angiogenesis and tumour growth
The Scripps Research Institute 1272173*
Combination product comprising a non-steroidal antiandrogen and an EGFR tyrosine kinase inhibitor
AstraZeneca 1272174*
IL-8 receptor antagonists
SmithKline Beecham 1272175*
Adamantyl derivatives as anti-cancer agents
Galderama Research and Development 1272176*
Method and formulation for treating resistance to antihypertensives and related conditions
Neurim Pharmaceuticals 1272177*
Bilirubin or biliverdin degradation fragments
Medical Research Council 1272178*
Hydrophilic molecular disperse solutions of carvedilol
F Hoffmann-La Roche 1272179*
Concentrated solutions of carvedilol
F Hoffmann-la Roche 1272180*
Modified release formulations containing a hypnotic agent
Synthon 1272181*
Use of sabcomeline in the treatment of anxiety
SmithKline Beecham 1272182*
Methods and compsns useful in enhancing oxygen delivery to cells
Niadyne Corp; University of Kentucky Research Foundation 1272183*
Pharmaceutical compsns comprising salmetrol and ipratropium
Glaxo Group 1272184*
Use of quinazoline derivatives as angiogenesis inhibitors
AstraZeneca 1272185*
Therapeutic combinations of antihypertensive and antiangiogenic agents
AstraZeneca 1272186*
Use of dopamine-D3 receptor ligands for the treatment of diseases of the central nervous system
BASF 1272187*
Use of EGFR tyrosine kinase inhibitors for treating breast cancer
The University of Manchester 1272188*
Inhibition of cyclooxygenase-2 activity
Celgene Corp 1272189*
A use of galantamine for the treatment of Alzheimer's disease; targeting the underlying cause of the disease
Janssen Pharmaceutica 1272190*
An efficacious dosage regimen of galantamine that reduces side effects
Janssen Pharmaceutica 1272191*
A use of galantamine for the treatment of neuropsychiatric behaviour associated with Alzheimer's disease
Janssen Pharmaceutica 1272192*
Synergistic methods and compsns for treating cancer
Bristol-Myers Squibb 1272193*
Compsn for use in the treatment of ocular hypertension and glaucoma
Sucampo 1272194*
Use of fulvestrant for the treatment of resistant breast cancer
AstraZeneca 1272195*
Methods of making the 4-N-butylcyclohexanoic acid and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical uses
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 1272196*
Combination of lecithin with ascorbic acid
Javor, Andras 1272197*
Use of organophosphorus compounds for producing a medicament for treating infections
Jomaa Pharmaka 1272198*
Combination therapies with vascular damaging activity
Angiogene Pharmaceuticals 1272199*
Divided dose therapies with vascular damaging activity
Angiogene Pharmaceuticals 1272200*
Use of compatible solutes as substances having free radical scavenging properties
Bitop gesellschaft fuer biotechnische Optimierung 1272201*
Multiple drug resistance reversal agent
Brigham Young University 1272202*
Treatment of disorders by implanting stem cells and/or progeny
Board of Regents of the University of Texas System 1272203*
Soft tissue and bone augmentation and bulking utilising muscle-derived progenitor cells, compsns and treatments thereof
University of Pittsburgh 1272204*
Sialoadhesin factor-2 antibodies
SmithKline Beecham 1272205*
Non-mammalian GNRH analogues and uses thereof in tumour cell growth regulation and cancer therapy
Siler-Khodr, Theresa; Khodr, Gabriel 1272206*
Method for treating pain by peripheral administration of a neurotoxin
Allergan 1272207*
Use of VEGF and homologues to treat neuron disorders
Vlaams Interuniversitair Instituut voor Biotechnologie 1272208*
Use of CRF receptor agonists for the treatment or prophylaxis of diseases, for example neurodegenerative diseases
Aventis Pharmaceutical Products 1272209*
Chimeric nontoxic mutants of enterotoxins as mucosal adjuvants for cell-mediated or humoral immunity
The UAB Research Foundation 1272210*
Methods and treatments for treating neoplasms
Kline, Ellis 1272211*
Migraine and vasodilation treatment
The Queen's University of Belfast 1272212*
Microbial delivery system
Panacea Pharmaceuticals 1272213*
Vaccine against cancerous diseases with is based on mimotypes of antigens expressed by tumour cells
Bio Life Science 1272214*
Pharmaceutical preparations comprising modified peptides
Cisterm Biotechnologies 1272215*
A vaccine comprising Lactobacilli for treating prostate inflammation and benign prostate hyperplasias
Vakcina 1272216*
Use of inhibition of a GAS6 function for of a GAS6 receptor for preventing and treating a cardiovascular disease
Vlaams Interuniversitair Instituut voor Biotechnologie 1272217*
A pharmaceutical compsn for treatment of acute, chronic pain and/or neuropathic pain and migraines
Pfizer Products 1272218*
New combination of a beta-blocker and a cholesterol-lowering agent
AstraZeneca 1272219*
Formulation for the prevention of cardiovascular disease
Wald, Nicholas; Law, Malcolm 1272220*
Peptide conjugates for drug delivery
Implyx 1272221*
Compsns for drug delivery
Implyx 1272222*
Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
KTB Tumorforschungsgesellschaft 1272223*
